Levofloxacin Accord-Uk

Levofloxacin, the active ingredient in Levofloxacin Accord-Uk, is a fluoroquinolone antibiotic presented as a topical ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in patients who require targeted antimicrobial therapy.

GNH USA supplies Levofloxacin Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability, regulatory compliance, and responsive technical support.

Levofloxacin Accord-Uk is used to treat bacterial ocular infections by targeting pathogenic bacteria in the eye.

- Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of redness and discharge. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Other ocular bacterial infections: provides broad‑spectrum coverage for susceptible Gram‑negative and Gram‑positive organisms.

Levofloxacin ocular administration can be associated with local and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Increased tearing or watery discharge. - Blurred vision temporarily. - Foreign body sensation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Corneal ulcer worsening or perforation. - Tendon rupture (systemic absorption). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe hypersensitivity with skin rash. - Vision loss due to ocular toxicity.

Before initiating therapy, clinicians should evaluate patient‑specific factors and follow safe handling practices.

- Allergy assessment: verify no known hypersensitivity to fluoroquinolones. - Tendon health: avoid use in patients with a history of tendon disorders. - Corneal integrity: use with caution in eyes with epithelial defects. - Systemic exposure: monitor for signs of systemic absorption, especially in prolonged use. - Pregnancy and lactation: assess risk‑benefit as safety data are limited. - Store at room temperature: keep in the original container, protect from moisture and light.

Levofloxacin ocular drops may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones (e.g., oral levofloxacin): risk of additive toxicity. - Corticosteroid eye drops: may increase risk of corneal ulceration. - Anticholinergic ophthalmic agents: may reduce ocular surface healing.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may heighten ocular irritation. - Herbal supplements containing quinine: potential additive fluoroquinolone effect. - Topical anesthetics: may exacerbate corneal toxicity when used together.